MAM
ADAP
MPM Asset Management’s Adaptimmune Therapeutics ADAP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.15M | Sell |
4,809,677
-526,038
| -10% | -$126K | 2.66% | 5 |
|
|
2025
Q1 | $1.05M | Sell |
5,335,715
-219,746
| -4% | -$43.3K | 1.51% | 6 |
|
|
2024
Q4 | $2.99M | Hold |
5,555,461
| – | – | 2.41% | 5 |
|
|
2024
Q3 | $5.28M | Hold |
5,555,461
| – | – | 3.63% | 6 |
|
|
2024
Q2 | $5.42M | Hold |
5,555,461
| – | – | 2.97% | 6 |
|
|
2024
Q1 | $8.78M | Hold |
5,555,461
| – | – | 3.58% | 6 |
|
|
2023
Q4 | $4.41M | Sell |
5,555,461
-731,640
| -12% | -$580K | 2.16% | 6 |
|
|
2023
Q3 | $4.9M | Hold |
6,287,101
| – | – | 2.63% | 6 |
|
|
2023
Q2 | $5.82M | Buy |
+6,287,101
| New | +$5.82M | 2.85% | 6 |
|